Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?
JAMA Surgery · 2023
DOI: 10.1001/jamasurg.2022.5790 ↗Kurz gefasst
Kommentar in der Zeitschrift JAMA Surgery, 2023. Verfasst von Michelle B Mulder und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, University of California, San Francisco. Hauptthemen laut MEDLINE: Thyroidectomy, Thyroid Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, University of California, San Francisco.
Zitieren
APA
Mulder, M. B., & Duh, Q. Y. (2023). Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?. JAMA Surgery. https://doi.org/10.1001/jamasurg.2022.5790
Vancouver
Mulder MB, Duh QY. Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?. JAMA Surgery. 2023. doi:10.1001/jamasurg.2022.5790
BibTeX
@article{Mulder2023,
author = {Mulder, Michelle B and Duh, Quan-Yang},
title = {Is Lobectomy as Effective as Total Thyroidectomy in Treating Patients With Intermediate-Risk Papillary Thyroid Carcinoma With Lateral Lymph Node Metastasis?},
journal = {JAMA Surgery},
year = {2023},
doi = {10.1001/jamasurg.2022.5790}
}
EUVIMED